| Literature DB >> 31132994 |
Malinee Laopaiboon1, Pisake Lumbiganon2, Siwanon Rattanakanokchai1, Warut Chaiwong3, João Paulo Souza4, Joshua P Vogel5,6, Rintaro Mori7, Ahmet Metin Gülmezoglu8.
Abstract
BACKGROUND: 2500 g has been used worldwide as the definition of low birthweight (LBW) for almost a century. While previous studies have used statistical approaches to define LBW cutoffs, a LBW definition using an outcome-based approach has not been evaluated. We aimed to identify an outcome-based definition of LBW for live births in low- and middle-income countries (LMICs), using data from a WHO cross-sectional survey on maternal and perinatal health outcomes in 23 countries.Entities:
Keywords: Early neonatal mortality; Low birthweight; Outcome-based definition
Mesh:
Year: 2019 PMID: 31132994 PMCID: PMC6535858 DOI: 10.1186/s12887-019-1546-z
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Fig. 1Flow chart of inclusion and exclusion of study neonates
Country-specific birthweight and early neonatal mortality distribution of singleton liveborn births
| Countries | Number of facilities | Number of newborns | Birthweight (g) | Early Neonatal Mortality (%) | |||
|---|---|---|---|---|---|---|---|
| Mean | (SD) | < 1500 (%) | < 2500 (%) | ||||
| Total | 344 | 205,648 | 2902 | (413) | 1.0 | 12.0 | 0.8 |
| Africa | 118 | 52,603 | 2935 | (389) | 0.8 | 9.9 | 1.1 |
| Algeria | 18 | 7516 | 3025 | (390) | 1.0 | 7.4 | 1.3 |
| Angola | 15 | 3920 | 2903 | (405) | 1.2 | 11.8 | 0.5 |
| Congo | 21 | 6767 | 2874 | (392) | 0.6 | 14.4 | 1.0 |
| Kenya | 20 | 13,586 | 2921 | (395) | 1.0 | 9.7 | 1.8 |
| Niger | 11 | 6526 | 2906 | (381) | 0.5 | 11.6 | 0.4 |
| Nigeria | 21 | 5704 | 2932 | (380) | 0.9 | 8.2 | 0.8 |
| Uganda | 12 | 8584 | 2964 | (363) | 0.6 | 7.7 | 1.1 |
| Asia | 112 | 85,222 | 2838 | (406) | 0.8 | 14.2 | 0.7 |
| Cambodia | 5 | 4457 | 2897 | (383) | 0.8 | 9.3 | 1.1 |
| China | 21 | 9357 | 3045 | (332) | 0.4 | 5.5 | 0.3 |
| India | 20 | 22,008 | 2653 | (405) | 1.2 | 22.1 | 1.1 |
| Nepal | 8 | 6852 | 2786 | (386) | 0.5 | 13.7 | 0.9 |
| Philippines | 17 | 11,732 | 2819 | (419) | 1.3 | 16.2 | 1.1 |
| Sri Lanka | 14 | 13,191 | 2846 | (381) | 0.6 | 15.5 | 0.2 |
| Thailand | 12 | 8068 | 2939 | (380) | 0.7 | 10.8 | 0.4 |
| Viet Nam | 15 | 9557 | 2997 | (335) | 0.3 | 5.7 | 0.1 |
| Latin America | 114 | 67,823 | 2958 | (428) | 1.4 | 10.8 | 0.7 |
| Argentina | 14 | 6661 | 2975 | (453) | 1.9 | 11.0 | 0.5 |
| Brazil | 19 | 10,955 | 2956 | (437) | 1.5 | 11.6 | 0.8 |
| Cuba | 17 | 8300 | 3013 | (379) | 0.7 | 8.0 | 0.2 |
| Ecuador | 14 | 9666 | 2898 | (432) | 1.5 | 12.4 | 0.7 |
| Mexico | 21 | 15,716 | 2932 | (429) | 1.5 | 11.6 | 0.6 |
| Nicaragua | 6 | 4271 | 2946 | (384) | 0.7 | 9.5 | 1.0 |
| Paraguay | 6 | 2001 | 2990 | (442) | 1.6 | 10.4 | 1.1 |
| Peru | 17 | 10,253 | 2997 | (438) | 1.7 | 9.8 | 1.0 |
Distribution of individual potential confounding factors by birthweight
| Birthweight (g) | n | Gestational age | Cesarean section | Breech presentation at birth | Maternal complicationsa | |
|---|---|---|---|---|---|---|
| Mean | (SD) | (%) | (%) | (%) | ||
| Overall | 205,648 | 38.5 | (2.0) | 49,964 (24.3) | 9099 (4.4) | 34,642 (16.9) |
| < 1500 | 2072 | 30.6 | (4.1) | 38.9 | 18.6 | 25.3 |
| 1500–1599 | 602 | 33.1 | (3.2) | 32.4 | 11.1 | 20.3 |
| 1600–1699 | 521 | 33.7 | (3.1) | 39.3 | 12.1 | 22.5 |
| 1700–1799 | 811 | 34.4 | (3.0) | 35.8 | 12.1 | 20.3 |
| 1800–1899 | 973 | 34.6 | (2.9) | 35.9 | 10.4 | 22.1 |
| 1900–1999 | 1032 | 35.2 | (2.9) | 36.7 | 9.5 | 23.3 |
| 2000–2099 | 2807 | 36.7 | (2.6) | 26.7 | 7.5 | 15.7 |
| 2100–2199 | 2165 | 36.9 | (2.5) | 29.7 | 7.3 | 19.2 |
| 2200–2299 | 3817 | 37.2 | (2.3) | 26.2 | 6.4 | 15.6 |
| 2300–2399 | 4178 | 37.6 | (2.0) | 25.5 | 5.2 | 18.2 |
| 2400–2499 | 5628 | 37.9 | (2.0) | 25.9 | 5.5 | 18.7 |
| 2500–3499 | 181,042 | 38.8 | (1.6) | 23.7 | 3.9 | 16.6 |
All variables differed significantly by birthweight categories (p-value < 0.001)
aMaternal complications included chronic hypertension, cardiac disease, renal disease, chronic respiratory condition, diabetes mellitus, malaria, sickle cell anaemia, severe anaemia, pyelonephritis or urinary infection, HIV/AIDS, Thalassemia and other medical conditions
Fig. 2Adjusted odds ratios with 95% CI of early neonatal mortality by birthweight in the total population. Solid red line shows the adjusted OR 2.0 for clinical significance
Rate and adjusted odds ratios of early neonatal mortality by birthweight
| Birthweight (g) | n | Early Neonatal Mortalitya | |
|---|---|---|---|
| Rate (%) | Adjusted OR (95% CI) | ||
| < 1500 | 2072 | 29.0 | 32.0 (25.6, 40.0) |
| 1500–1599 | 602 | 13.8 | 17.9 (13.3, 24.1) |
| 1600–1699 | 521 | 9.6 | 12.5 (8.8, 17.7) |
| 1700–1799 | 811 | 6.2 | 9.5 (6.8, 13.2) |
| 1800–1899 | 973 | 6.8 | 10.5 (7.8, 14.1) |
| 1900–1999 | 1032 | 3.6 | 5.9 (4.1, 8.5) |
| 2000–2099 | 2807 | 3.1 | 6.6 (5.2, 8.5) |
| 2100–2199 | 2165 | 1.6 | 3.8 (2.7, 5.5) |
| 2200–2299 | 3817 | 1.0 | 2.6 (1.9, 3.7) |
| 2300–2399 | 4178 | 0.6 | 1.7 (1.1, 2.6) |
| 2400–2499 | 5628 | 0.7 | 2.3 (1.7, 3.1) |
| 2500–3499 | 181,042 | 0.3 | 1.0 |
Adjusted for gestational age, mode of delivery, fetal presentation at delivery, maternal complications and complexity index
aROC = 0.9118
Rate and adjusted odds ratios of early neonatal mortality by birthweight and regions
| Birthweight (g) | Early neonatal mortality | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Africaa ( | Asiab ( | Latin Americac ( | |||||||
| n | Rate (%) | Adjusted OR (95% CI) | n | Rate (%) | Adjusted OR (95% CI) | n | Rate (%) | Adjusted OR (95% CI) | |
| < 1500 | 435 | 36.8 | 30.4 (21.1, 43.7) | 677 | 28.5 | 54.3 (37.4, 78.9) | 960 | 25.8 | 18.1 (11.5, 28.5) |
| 1500–1599 | 114 | 22.8 | 20.6 (11.9, 35.7) | 327 | 11.9 | 23.1 (14.9, 36.0) | 161 | 11.2 | 13.9 (7.5, 25.5) |
| 1600–1699 | 116 | 14.7 | 11.0 (6.0, 20.4) | 209 | 7.7 | 15.6 (8.5, 28.5) | 196 | 8.7 | 12.4 (6.8, 22.8) |
| 1700–1799 | 143 | 7.7 | 6.4 (3.2, 12.7) | 387 | 5.9 | 13.4 (8.2, 22.0) | 281 | 5.7 | 8.8 (4.8, 16.1) |
| 1800–1899 | 175 | 12.6 | 11.5 (6.8, 19.5) | 458 | 7.0 | 16.3 (10.6, 25.2) | 340 | 3.5 | 5.2 (2.7, 10.3) |
| 1900–1999 | 228 | 6.6 | 6.5 (3.7, 11.6) | 431 | 2.8 | 7.4 (3.9, 13.9) | 373 | 2.7 | 4.4 (2.2, 9.0) |
| 2000–2099 | 636 | 4.1 | 5.5 (3.6, 8.6) | 1571 | 2.7 | 7.4 (5.1, 10.7) | 600 | 3.2 | 8.3 (4.8, 14.3) |
| 2100–2199 | 481 | 2.7 | 3.6 (2.0, 6.5) | 999 | 0.8 | 2.7 (1.3, 5.6) | 685 | 2.0 | 6.1 (3.4, 10.9) |
| 2200–2299 | 682 | 2.2 | 3.0 (1.8, 5.2) | 2225 | 0.7 | 2.3 (1.4, 4.0) | 910 | 0.9 | 3.0 (1.4, 6.3) |
| 2300–2399 | 901 | 1.1 | 1.7 (0.9, 3.3) | 2043 | 0.3 | 1.3 (0.6, 2.7) | 1234 | 0.6 | 2.6 (1.3, 5.5) |
| 2400–2499 | 1293 | 1.3 | 2.2 (1.3, 3.6) | 2772 | 0.5 | 2.2 (1.3, 3.7) | 1563 | 0.6 | 3.0 (1.5, 5.8) |
| 2500–3499 | 47,399 | 0.5 | 1.0 | 73,123 | 0.2 | 1.0 | 60,520 | 0.1 | 1.0 |
Adjusted for gestational age, mode of delivery, fetal presentation at delivery, maternal complications and complexity index
aROC = 0.8804
bROC = 0.9101
cROC = 0.9245
Fig. 3Adjusted odds ratios with 95% CI of early neonatal mortality by birthweight in the three regions. Solid red line shows the adjusted OR 2.0 for clinical significance